Saturday 17 October 2026
Export IQV’s income statement to Excel — free account
IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
266.90
4.14
−1.53%
Follow IQV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 22.75% | 22.46% | 21.42% | 19.36% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 5 | 4 | 5 | |
| 4.70% | 4.86% | 4.79% | 4.59% | ||
ROIC |
6.80% | 6.85% | 6.75% | 7.07% | |
Return on Tangible Assets |
(67.34%) | (86.94%) | (87.40%) | (64.02%) | |
Average Days of Receivables |
72.79 | 74.07 | 76.69 | 76.06 | |
Free Cash Flow per Share |
13.60 | 13.01 | 12.37 | 13.43 | |
Free Cash Flow |
2,259.00 | 2,191.00 | 2,126.00 | 2,286.00 | |
Capital Expenditures |
(560.00) | (513.00) | (528.00) | (518.00) | |
| Other line items | |||||
Cash ROIC |
9.27% | 9.02% | 8.68% | 9.85% | |
Accounts Receivable Turnover |
5.00 | 4.98 | 4.89 | 4.85 | |
Accounts Payable Turnover |
3.25 | 3.10 | 2.93 | 3.02 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
115.68 | 119.18 | 125.84 | 123.03 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.16) | (0.16) | (0.16) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.12% | 11.98% | 12.26% | 12.47% | |
Share Based Compensation of Revenue |
1.62% | 1.44% | 1.51% | 1.48% | |
Interest Coverage |
2.85 | 2.91 | 2.99 | 3.08 | |
Operating CF/Net income |
2.05 | 1.95 | 1.95 | 2.19 | |
Depreciation/Fixed assets |
2.21 | 2.31 | 2.19 | 2.19 | |
Capex/Depreciation |
(0.46) | (0.43) | (0.45) | (0.45) | |
Revenue per Share |
102.25 | 98.76 | 94.88 | 93.44 | |
Operating CF per Share |
16.97 | 16.06 | 15.44 | 16.47 | |
Capex per Share |
(3.37) | (3.05) | (3.07) | (3.04) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates